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Recent studies suggest that endogenous neurotrophins
play a central role in the patterning of cortical
connections and in cortical synaptic physiology. Do these
effects of neurotrophins reflect independent cellular
events, or are they manifestations of a single cellular
mechanism central to developmental plasticity?
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Much of our understanding of the activity-dependent
development of the cortex has been derived from studies
of thalamic projections to the visual cortex. Axons from
the lateral geniculate nucleus (LGN) of the thalamus are
initially intermixed within layer 4 of the visual cortex. A
process of eye-specific axon segregation leads to the for-
mation of ocular dominance columns, which include
groups of neurons that respond preferentially to stimula-
tion of one eye (Figure 1). Monocular deprivation during
a restricted period in development — called the critical
period — leads to a shift in ocular dominance columns in
favor of the non-deprived eye [1]. The formation of
ocular dominance columns can be prevented by intraocu-
lar injection of tetrodotoxin, a sodium channel blocker,
suggesting that the process requires action potential
activity [2]. It has also been shown that blockade of the
N-methyl-D-aspartate (NMDA) class of glutamate
receptors in the cortex prevents ocular dominance
plasticity, indicating a role for synaptic transmission in
this process [3]. There has been much interest over the
past few years in identifying the molecular mechanisms
that mediate these activity-dependent changes in the
developing cortex.
One class of molecules that has been suggested to play a
role in the development of thalamocortical projections is
the neurotrophin family of growth factors. Neurotrophins
are small, secreted proteins that have been found to play
important roles in various aspects of nervous system
development. Members of this family, which includes
nerve growth factor (NGF), brain-derived neurotrophic
factor (BDNF), neurotrophin-3 (NT-3), and neurotrophin-
4/5 (NT-4/5), were initially identified as factors that
promote the survival of various classes of neurons. As
discussed below, a number of recent studies have
provided evidence that neurotrophins can also exert
marked influences on cellular events that may be central
to cortical plasticity.
Neurotrophins and thalamocortical patterning
A long-standing hypothesis concerning the patterning of
axonal projections holds that developing axons require
target-derived factors for their survival, and that ingrowing
axons compete for limiting amounts of such target-derived
trophic factors. It has also been proposed that, during thal-
amocortical development, more active thalamic afferents
have a competitive advantage. One class of molecules that
may serve as target-derived trophic factors are the
neurotrophins. A prediction of this possibility is that an
excess of target-derived neurotrophins should eliminate
competition among thalamic afferents and, indeed,
Cabelli et al. [4] have shown that infusion of BDNF or
NT-4/5 into the visual cortex of kittens during the critical
period prevents the segregation of geniculocortical axons
into ocular dominance columns. 
Although this observation indicates that exogenously
applied neurotrophins can influence the patterning of
thalamic axons in the cortex, it does not show whether
endogenous neurotrophins have a similar function. Cabelli
et al. [5] have recently addressed this question by infusing
neurotrophin ‘receptor-bodies’ into the visual cortex
during the critical period. Receptor-bodies are fusion pro-
teins consisting of the ligand-binding domain of a receptor
— in this case one of the neurotrophin receptors, Trk-A,
Trk-B or Trk-C — fused to the Fc portion of human
immunoglobulin G (IgG). They found that infusion of
Trk-B–IgG, but not Trk-A–IgG or Trk-C–IgG, into the
visual cortex of kittens blocked the segregation of LGN
axons into ocular dominance columns. This observation
suggests that a Trk-B ligand, most likely BDNF or NT-
4/5, participates in the eye-specific segregation of genicu-
locortical axons (Figure 1).
These elegant experiments suggest that endogenous
neurotrophins play an important role in the patterning of
thalamocortical projections, but the specific cellular func-
tion of the neurotrophins in this process is not easily
inferred. One possibility is that BDNF or NT-4/5 acts
principally to regulate the growth of thalamic axons within
layer 4. Neurotrophin infusion may lead to an increased
growth of thalamic axons within layer 4, and Trk-B–IgG
infusions may arrest the ingrowing axons in an immature,
unsegregated state. Alternatively, BDNF or NT-4/5 may
play a central role in activity-dependent synaptic plasticity
and may mediate the stabilization or growth of appropriate
synaptic contacts. Infusion of neurotrophins may lead to
the stabilization of inappropriate synapses, and the
sequestration of neurotrophins by Trk-B–IgG receptor-
bodies might prevent all forms of activity-dependent
rearrangements from taking place. Both of these potential
mechanisms are consistent with the results of the
neurotrophin perturbation experiments. Moreover, as dis-
cussed below, emerging evidence suggests that neu-
rotrophins can also have major effects on the dendritic
development of postsynaptic cortical neurons, which
could indirectly influence the elaboration of presynaptic
axon terminals.
Neurotrophins and dendritic growth
In a recent series of experiments, McAllister and
colleagues [6,7] have made some interesting observations
regarding the influence of neurotrophins on dendritic
development in cortical slice cultures. In their initial study
[6], the authors reported that cells in different layers of the
cortex respond differentially to neurotrophin stimulation.
For example, BDNF promotes the growth of dendrites of
layer 4 and 5 neurons, but suppresses the development of
basal dendrites in layer 6. They also noted that cells in a
given layer respond distinctly to stimulation by different
neurotrophins. Layer 4 neurons, which respond positively
to BDNF stimulation, are virtually unaffected by NT-3
stimulation. These findings indicate that neurotrophins
can have marked layer-specific effects on the dendritic
development of cortical neurons.
These observations have recently been extended to
include an analysis of the role of endogenous neu-
rotrophins in the regulation of dendritic growth. By using
receptor-bodies to inhibit the function of endogenous
neurotrophins, McAllister et al. [7] found that treatment of
cortical slices with Trk-B–IgG or Trk-C–IgG had opposite
effects on the same population of neurons. Whereas Trk-
B–IgG treatment inhibited dendritic growth of layer 4
neurons, Trk-C–IgG treatment promoted it, suggesting
that the endogenous Trk-B ligands, BDNF and NT-4/5,
and the Trk-C ligand, NT-3, have opposing effects on the
dendritic growth of layer 4 neurons.
This result is particularly striking, as stimulation of both
Trk-B and Trk-C receptors leads to the activation of the
Ras–mitogen activated protein (MAP) kinase signal trans-
duction cascade, and therefore would be expected to have
similar cellular consequences. The distinct effects of
inhibiting BDNF and NT-3 strongly suggest that there are
important differences in the Trk-B and Trk-C signaling
pathways that remain to be identified. Although it is not yet
clear whether neurotrophins can influence dendritic growth
during the critical period, given the findings of the slice
culture experiments that possibility must be taken into
account in interpreting the results of neurotrophin or Trk-
B–IgG infusion experiments described above.
Neurotrophins and synaptic plasticity
The cellular effects of neurotrophins on thalamic axons
and cortical dendrites are seen over the course of days, and
therefore do not reveal whether these factors can have
acute effects on the physiology or function of cortical
neurons. In the past few years, this possibility has received
much attention from experiments that have examined the
role of neurotrophins in synaptic plasticity. In 1995, Kang
and Schuman [8] reported that acute treatment of adult
hippocampal slices with BDNF or NT-3 led to a rapid
enhancement of synaptic transmission, and that this form
of synaptic enhancement did not occlude long-term
potentiation (LTP), a form of synaptic plasticity that has
been extensively investigated in the hippocampus and
neocortex as a cellular model of learning and memory. 
This observation generated a great deal of excitement, as
well as some level of controversy, in part because some sub-
sequent reports were not entirely consistent with this
finding. For example, Figurov et al. [9] reported that BDNF
promoted the induction of LTP in young, but not adult,
hippocampal slices. Moreover, they found that, in the
absence of activity, BDNF did not affect the efficacy of
basal synaptic transmission. Although these differences
have generally been attributed to variations in the details of
the experimental procedure, they underscore the point that
there is not yet universal agreement on the specific role of
neurotrophins in the modulation of synaptic transmission.
A second line of evidence that supports a role for BDNF
in synaptic plasticity has come from analysis of mice with a
targeted disruption of the BDNF gene. Two different
groups have reported that LTP is impaired in BDNF null
mice [10,11]. Importantly, this defect can be rescued by
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Figure 1
Diagrammatic representation of the effects of neurotrophin
perturbation on ocular dominance column formation. Infusion of BDNF,
NT-4/5 or Trk-B–IgG prevents the formation of ocular dominance
columns, but the effects of these perturbations on individual LGN
axons may be distinct, as shown here. See text for details.
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BDNF provided either by retroviral infection of hip-
pocampal slices [12] or by bath application of BDNF [11],
suggesting that the defect is likely to be related to an
acute requirement for BDNF rather than being a develop-
mental consequence of the absence of BDNF. It is also
noteworthy that the heterozygous animals also show
defective LTP, suggesting that the levels of BDNF may
be an important determinant of synaptic plasticity.
Recent observations suggest that, as in the hippocampus,
plasticity in the cortex can also be modulated by neu-
rotrophins. Two findings in this regard are particularly
noteworthy. Akaneya et al. [13] have reported that applica-
tion of recombinant BDNF can prevent the induction of
long-term depression (LTD) in layer 2/3 of cortex in
response to low frequency stimulation of layer 4. More
recently, the same group [14] found that treatment with
BDNF — but not NT-3 or NGF — could lead to an
enhancement of field potentials recorded in layer 2/3 fol-
lowing layer 4 stimulation. They also found that bath
application of Trk-B–IgG or K252a (a Trk receptor family
inhibitor) could prevent the induction of LTP in these
slices, suggesting that endogenous BDNF may be
required for certain forms of synaptic plasticity in cortical
slices. Although these findings require further investiga-
tion, they suggest that neurotrophins can have rapid and
pronounced effects on cortical synaptic physiology.
Perspectives
The recent evidence that neurotrophins modulate both
synaptic plasticity and cortical development has renewed
interest in the possibility that synaptic plasticity and activ-
ity-dependent ocular dominance plasticity may share
common underlying mechanisms. One interpretation of
these findings is that neurotrophins directly contribute to
synaptic plasticity, and that these synaptic changes in turn
are responsible for the activity-dependent remodeling of
thalamocortical axons that is the basis of ocular dominance
column segregation. 
This model is appealing, because it unifies the mechanism
underlying two forms of activity-dependent plasticity.
Recent studies in the rat somatosensory [15] and visual
[16] cortex, which show that LTP can be induced during a
time that coincides with the critical period and that the
two events have similar pharmacological responses,
provide indirect support for this possibility. It should be
noted, however, that such correlations do not prove that
synaptic plasticity and activity-dependent reorganization
of thalamic axons are causally related events, and further
work is necessary before such a conclusion can be drawn.
With regard to the effects of neurotrophins on the activity-
dependent reorganization of thalamic afferents, there are
several important issues that remain to be addressed. It will
be of particular interest to explore how BDNF or NT-4/5
might contribute to the growth or stabilization of appropri-
ate thalamic axons. One possibility is that, in the postsy-
naptic neuron,  the neurotrophin is transported to active
synapses, leading to specific stabilization of those synapses.
Another possibility is that BDNF or NT-4/5 is released by
the postsynaptic neuron in a relatively non-specific way
and acts as a permissive signal for activity-dependent
synaptic plasticity. A third possibility is that active thalamic
axons are more effective in responding to target-derived
neurotrophins, even if the factors are not released in a
synapse-specific manner. These possible modes of action
by which neurotrophins might affect synaptic physiology
and afferent growth are not mutually exclusive, and addi-
tional experiments are required to determine whether one
or more of these mechanisms are indeed involved.
Another issue that needs to be addressed is the
electrophysiological response of cortical neurons in vivo
under conditions of neurotrophin or Trk-B–IgG infusion.
Given the extensive evidence that inhibition of neuronal
activity can prevent ocular segregation, it is important to
determine whether perturbation of neurotrophins has
acute effects on synaptic physiology in vivo. It would also
be interesting to know whether the effects of monocular
deprivation on the patterning of thalamic afferents can be
rescued by providing exogenous neurotrophins. Monocu-
lar deprivation typically leads to the retraction of thalamic
axons receiving inputs from the deprived eye. If this is
because of their inability to access target-derived BDNF
or NT-4/5, then infusion of these neurotrophins should
rescue this defect. A failure to rescue would be more con-
sistent with the possibility that BDNF acts as a permissive
factor for ocular dominance plasticity. The answers to
these questions will be critical as we try to understand the
specific function of neurotrophins in cortical plasticity.
The observations from recent neurotrophin perturbation
experiments have provided important evidence in support
of a role for these factors in cortical development. Despite
this progress, we are still far from understanding the
mechanisms by which neurotrophins affect various cellular
events in the cortex, and from knowing whether they are
manifestations of a single neurotrophin-regulated cellular
event. It will be of interest to see which of the many
current hypotheses survive more rigorous investigations,
which are sure to come in short order.
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